Clinical Trial Update: Tumor-Derived FGF19

View source ↗

Summary

This clinical trial update concerns a study evaluating tumor-derived FGF19 in colorectal cancer and breast cancer, with the trial currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer

Drugs mentioned

• Tumor-Derived FGF19 (FGF19)

Snippet

Sponsor: University of Central Florida | Conditions: Colorectal Cancer, Breast Cancer | Status: RECRUITING